list of glp-1 agonists Clinical Trials Evaluating the Cardiovascular Efficacy and List of approved and pending

www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014

If you have established atherosclerotic cardiovascular disease, your healthcare provider will likely recommend one of these agents with proven cardiovascular benefit

Remember, the prescription claims you submit today are the audits of the future

- Pathology: Glanzmann thrombasthenia is a hereditary deficiency of GPIIb/IIIa, causing mucocutaneous bleeding with normal platelet count but impaired aggregation

Although we sought to minimize this selection bias by including all eligible participants, unmeasured confounding must be considered